美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Propanc Biopharma, Inc.

4.00

0.0000

成交量：7,005.00

成交额：2.80万

市值：4,644.72万

市盈率：-0.08

高：4.00

开：4.00

低：4.00

收：4.00

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Propanc Biopharma, Inc.

交易所：

PINK

成立时间：

2007

员工人数：

2

公司地址：

302, 6 Butler Street,Camberwell,Victoria,Australia

官网：

http://www.propanc.com

邮编：

3124

电话：

传真：

61 3 9882 9969

简介：

Propanc Biopharma, Inc.最初于2007年10月15日在澳大利亚维多利亚州墨尔本成立。2010年11月23日，该公司在特拉华州重新注册并重新注册。他们是一家发展阶段的医疗保健公司，目前专注于为患有胰腺癌、卵巢癌和癌症的患者开发新的癌症治疗方法。利用他们的科学和肿瘤学顾问，他们开发了一种合理的抗癌化合物复合配方，这些化合物共同发挥多种作用，旨在控制或防止肿瘤在体内复发和扩散。他们的主要候选产品PRP是他们新配方的变体，涉及酶原，即酶的无活性前体。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PPCB/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPCB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":4,"timestamp":1750449600000,"preClose":4,"halted":0,"volume":7005,"delay":15,"floatShares":11611800,"shares":11611800,"eps":-51.779603,"marketStatus":"休市中","change":0,"latestTime":"06-20 16:00:00 EDT 延时","open":4,"high":4,"low":4,"amount":28020.25,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-51.779603,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":4,"volumeRatio":3.3058048276331418},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","floatShares":11611800,"roa":"-298.55%","roe":"-767.20%","lyrEps":-1.798272,"volumeRatio":3.3058048276331418,"shares":11611800,"dividePrice":0,"high":4,"amplitude":0,"preClose":4,"low":4,"week52Low":0.0002,"pbRate":"2.57","week52High":102,"institutionHeld":0,"latestPrice":4,"eps":-51.779603,"divideRate":0,"volume":7005,"delay":15,"ttmEps":-51.779603,"open":4,"prevYearClose":0.0002,"prevWeekClose":8,"prevMonthClose":2.25,"prevQuarterClose":5.5,"fiveDayClose":8,"twentyDayClose":3.15,"sixtyDayClose":6.75},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":134729532,"yearFounded":2007,"employeeNum":2,"address":"302, 6 Butler Street,Camberwell,Victoria,Australia","zipCode":"3124","officePhone":"61 3 9882 0780","officeFax":"61 3 9882 9969"},"stockCompanyDetail":{"websiteUrl":"http://www.propanc.com","stockEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.1942},{"period":"3month","weight":121.0588},{"period":"6month","weight":82},{"period":"1year","weight":9.7792},{"period":"ytd","weight":42.0052}],"description":"Propanc Biopharma, Inc.最初于2007年10月15日在澳大利亚维多利亚州墨尔本成立。2010年11月23日，该公司在特拉华州重新注册并重新注册。他们是一家发展阶段的医疗保健公司，目前专注于为患有胰腺癌、卵巢癌和癌症的患者开发新的癌症治疗方法。利用他们的科学和肿瘤学顾问，他们开发了一种合理的抗癌化合物复合配方，这些化合物共同发挥多种作用，旨在控制或防止肿瘤在体内复发和扩散。他们的主要候选产品PRP是他们新配方的变体，涉及酶原，即酶的无活性前体。","exchange":"PINK","name":"Propanc Biopharma, Inc.","nameEN":"Propanc Biopharma, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPCB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-29","symbol":"PPCB","defaultRemindTime":1738161000000,"type":"split","dateTimestamp":1738126800000,"forFactor":60000,"toFactor":1,"ratio":60000},{"market":"US","date":"2023-05-23","symbol":"PPCB","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2020-11-19","symbol":"PPCB","defaultRemindTime":1605796200000,"type":"split","dateTimestamp":1605762000000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2019-06-24","symbol":"PPCB","type":"split","dateTimestamp":1561348800000,"forFactor":500,"toFactor":1,"ratio":500}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPCB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PPCB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PPCB","date":"2025-04-07","current":-0.048332,"percent":1,"low":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"high":-0.048332,"avg":-0.050058,"sd":0.000996,"marketCap":80703},"quantilePoints":[{"date":"2025-04-04","current":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.050633,"marketCap":84546},{"date":"2025-04-07","current":-0.048332,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"marketCap":80703}],"updateTime":1750496261067}}}